RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) compared with premix or addition of meal-time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta-analysis.

Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) compared with premix or addition of meal-time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta-analysis.

Add to Collection
2020 Nov Systematic Review and Meta Analysis Fist_Author_Year_PM

Full Author : ['Home, Philip', 'Blonde, Lawrence', 'Kalra, Sanjay', 'Ji, Linong', 'Guyot, Patricia', 'Brulle-Wohlhueter, Claire', 'Murray, Erin', 'Shah, Roshan', 'Sayre, Toby', 'Shaunik, Alka']
Journal Title : Diabetes, obesity & metabolism
Chapter : Section3
Journal Year : 2020
Cited by : Not Available

AIM: To assess the efficacy and safety of iGlarLixi, a fixed-ratio combination of insulin glargine 100 U/mL and lixisenatide, relative to premix insulin and other insulin options through network meta-analysis. METHODS: A systematic literature search ident.....

Keywords : ["insulin glarginelixisenatide fixedratio combination iglarlixi compare", "bayesian network metaanalysis", "mealtime insulin", "basal insulin", "type diabetes", "systematic review", "premix", "people", "addition"]